| 发明名称 |
FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE |
| 摘要 |
The invention relates to a method for predicting the risk of mortality of a patient suffering from end stage liver disease (ESLD), said method comprising a step of measuring the concentration of FGF23 in a blood sample obtained from said patient. |
| 申请公布号 |
WO2014184334(A1) |
申请公布日期 |
2014.11.20 |
| 申请号 |
WO2014EP60052 |
申请日期 |
2014.05.16 |
| 申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);UNIVERSITÉ PARIS DESCARTES;ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) |
发明人 |
FRIEDLANDER, GÉRARD;PRIE, DOMINIQUE |
| 分类号 |
G01N33/74 |
主分类号 |
G01N33/74 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
